Syndax Pharmaceuticals (SNDX) Return on Sales Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) Return on Sales Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.89 Bn | 1.54 Bn | 53.02 Mn | 4.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 |
| Dec 31, 2025 | 11.00 |
| Sep 30, 2025 | 5.00 |
| Jun 30, 2025 | 19.00 |
| Dec 31, 2024 | -11.00 |
| Sep 30, 2024 | -5.00 |
| Jun 30, 2024 | -20.00 |
| Dec 31, 2021 | 54.00 |
| Sep 30, 2021 | 52.00 |
| Jun 30, 2021 | -15.00 |
| Mar 31, 2021 | -32.00 |
| Dec 31, 2020 | -20.00 |
| Sep 30, 2020 | -16.00 |
| Jun 30, 2020 | -1.00 |
| Mar 31, 2020 | -2.00 |
| Dec 31, 2019 | 12.00 |
| Sep 30, 2019 | 9.00 |
| Jun 30, 2019 | 6.00 |
| Mar 31, 2019 | 14.00 |
| Dec 31, 2018 | -28.00 |